BSX
Price
$101.02
Change
+$2.10 (+2.12%)
Updated
Apr 24, 02:19 PM (EDT)
Capitalization
100.1B
90 days until earnings call
SYK
Price
$359.74
Change
+$2.63 (+0.74%)
Updated
Apr 24, 02:49 PM (EDT)
Capitalization
134.94B
7 days until earnings call
Ad is loading...

BSX vs SYK

Header iconBSX vs SYK Comparison
Open Charts BSX vs SYKBanner chart's image
Boston Scientific
Price$101.02
Change+$2.10 (+2.12%)
Volume$6.38K
Capitalization100.1B
Stryker
Price$359.74
Change+$2.63 (+0.74%)
Volume$100
Capitalization134.94B
BSX vs SYK Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. SYK commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Buy and SYK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BSX: $98.92 vs. SYK: $357.11)
Brand notoriety: BSX: Notable vs. SYK: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 139% vs. SYK: 88%
Market capitalization -- BSX: $100.1B vs. SYK: $134.94B
BSX [@Medical Specialties] is valued at $100.1B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 6 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • SYK’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SYK is a better buy in the short-term than BSX.

Price Growth

BSX (@Medical Specialties) experienced а +3.85% price change this week, while SYK (@Medical Specialties) price change was +3.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.08%. For the same industry, the average monthly price growth was -6.75%, and the average quarterly price growth was -2.65%.

Reported Earning Dates

BSX is expected to report earnings on Jul 23, 2025.

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+4.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than BSX($100B). BSX has higher P/E ratio than SYK: BSX (63.64) vs SYK (42.99). BSX YTD gains are higher at: 10.748 vs. SYK (-0.587). SYK has higher annual earnings (EBITDA): 4.93B vs. BSX (3.45B). SYK has more cash in the bank: 3.05B vs. BSX (865M). BSX has less debt than SYK: BSX (9.49B) vs SYK (13B). SYK has higher revenues than BSX: SYK (20.5B) vs BSX (14.2B).
BSXSYKBSX / SYK
Capitalization100B135B74%
EBITDA3.45B4.93B70%
Gain YTD10.748-0.587-1,830%
P/E Ratio63.6442.99148%
Revenue14.2B20.5B69%
Total Cash865M3.05B28%
Total Debt9.49B13B73%
FUNDAMENTALS RATINGS
BSX vs SYK: Fundamental Ratings
BSX
SYK
OUTLOOK RATING
1..100
7562
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
310
SMR RATING
1..100
7355
PRICE GROWTH RATING
1..100
4757
P/E GROWTH RATING
1..100
3331
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (23) in the Medical Specialties industry is somewhat better than the same rating for BSX (83). This means that SYK’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (3) in the Medical Specialties industry is in the same range as SYK (10). This means that BSX’s stock grew similarly to SYK’s over the last 12 months.

SYK's SMR Rating (55) in the Medical Specialties industry is in the same range as BSX (73). This means that SYK’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (47) in the Medical Specialties industry is in the same range as SYK (57). This means that BSX’s stock grew similarly to SYK’s over the last 12 months.

SYK's P/E Growth Rating (31) in the Medical Specialties industry is in the same range as BSX (33). This means that SYK’s stock grew similarly to BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXSYK
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
57%
Declines
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
41%
View a ticker or compare two or three
Ad is loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QSG5.160.50
+10.73%
QuantaSing Group Limited
TCOM58.231.36
+2.39%
Trip.com Group Limited
BLKB62.090.66
+1.07%
Blackbaud
PERI8.62-0.12
-1.37%
Perion Network Ltd
YOSH11.71-0.88
-6.96%
Yoshiharu Global Co

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+4.07%
ISRG - BSX
72%
Closely correlated
+1.92%
SYK - BSX
67%
Closely correlated
+2.58%
MMSI - BSX
62%
Loosely correlated
+2.47%
AORT - BSX
48%
Loosely correlated
+2.19%
IQV - BSX
45%
Loosely correlated
+2.40%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
+2.58%
BSX - SYK
67%
Closely correlated
+4.07%
ISRG - SYK
66%
Closely correlated
+1.92%
MDT - SYK
51%
Loosely correlated
+0.46%
MMSI - SYK
51%
Loosely correlated
+2.47%
A - SYK
50%
Loosely correlated
+2.13%
More